Evolent Health, a US-based company that has developed a population health and risk management platform for healthcare systems filed for an initial public offering on Tuesday that could raise up to $100m.
The company was founded by research and consultancy firm The Advisory Board Company and health insurer UPMC Health Plan in 2011. Evolent has not yet set a price for individual shares.
Originally known as VPHealth, Evolent operates a software platform that enables healthcare providers to provide value-based care taking into account clinical, financial and general population health data and available technology.
The company raised $20m in series A funding in 2011, according to a regulatory filing, before securing $100m in a 2013 series B round featuring both founding investors as well as private equity firm TPG Growth.
The series B round was extended to $101.3m in January 2014. UPMC, Advisory Board and TPG remain Evolent’s only external shareholders, though the IPO filing does not reveal the size of their individual stakes.
Evolent will use the proceeds to grow its market share, improve its competitive position and look at potential acquisitions. JP Morgan and Goldman Sachs are acting as joint book-running managers for the offering.